跳至主要内容
临床试验/EUCTR2006-004927-12-GB
EUCTR2006-004927-12-GB进行中(未招募)1 期

A double-blind randomised placebo controlled study of cotrimoxazole in the treatment of advanced pulmonary fibrosis - cotrimoazole in advanced fibrotic lung disease

St Helier Hospital NHS Trust0 个研究点目标入组 140 人开始时间: 2010年1月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male & female 40-80 yrs . History and investigationssupport a diagnosis of pulmonary fibrosis. Ct scan but biopsy not essential.
  • Patients maybe established on prednisolone (1-30mg) or have ceased prednisolone due to lack of effect.Patients must show oxygen desaturation on exercise to below 90% on shuttle walking test and score MRC dyspnoea score 3 or above
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Secondary causes of lung fibrosis, orsignificant COPD,Asthma, sarciod that could invalidate the study outcome measures. Those on lontterm oxygen, Heart disease and those unable to perform the shuttle walking test. Pregnant women, cotrimoxazole allergy, untreated B12 & folate deficiency Renal failure with creatinine above 180. Known G-6-PD deficiency

研究者

发起方
St Helier Hospital NHS Trust

相似试验

进行中(未招募)
不适用
A double-blind, randomised placebo controlled study of the effects of Acarbose on endothelial function, hemostatic and fibrinolytic plasmatic factors in patients with stable coronary artery disease and either impaired glucose intolerance or newly diagnosed diabetes mellitus1. To study the effect of Acarbose treatment on endothelial function as a potential mechanism for the beneficial effects of better postprandial glycemic control in patients with impaired glucose tolerance or newly diagnosed diabetes mellitus
EUCTR2004-002579-17-DEMedizinische Klinik B, Herzzentrum Ludwigshafen
已完成
不适用
A double blind, randomised placebo controlled study of the safety, reactogenicity and immunogenicity of two doses of orally administered human rotavirus vaccine (RIX4414) in healthy infants in South AfricaVaccine/immunizationInfections and InfestationsVaccination
ISRCTN37373664World Health Organization (WHO)/Department of Immunisation, Vaccines and Biologicals (IVB) (Switzerland)285
进行中(未招募)
1 期
a study of menthol for pain relief during photodynamic therapyActinic keratosis (pre-cancerous sun damage)on the face and scalpMedDRA version: 20.0 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders
EUCTR2015-002849-59-GBniversity of Dundee30
尚未招募
1 期
A double-blind, placebo controlled randomised study to assess the tolerability, safety, and preliminary efficacy of taurolidine-citrate lock solution (TauroLock™) in patients with recurrent pleural effusions requiring management with Indwelling Pleural Catheters for recurrent effusion drainage.
ACTRN12622001280796St John of God Midland Hospital18
招募中
3 期
The effect of using Growth Hormone in Invitro Fertilisation on livebirth ratesinfertility
ACTRN12609001060235Robinson Institute389